Singapore markets open in 5 hours 56 minutes

Centessa Pharmaceuticals plc (CNTA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.93+0.13 (+1.48%)
As of 03:00PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-138,417
-151,085
-216,207
-10,663
-5,061
Depreciation & amortisation
961
810
131
0
6
Deferred income taxes
-26,095
-26,529
-2,857
-
-
Stock-based compensation
30,356
29,392
24,965
336
236
Change in working capital
-21,823
-18,858
-2,831
-489
-1,006
Accounts payable
-5,157
-2,722
6,351
-49
855
Other working capital
-149,871
-160,511
-201,683
-10,630
-5,825
Other non-cash items
-
28
173
-
-
Net cash provided by operating activities
-149,790
-160,342
-200,546
-10,630
-5,825
Cash flows from investing activities
Investments in property, plant and equipment
-
-169
-1,137
-
-
Purchases of investments
-198,661
-264,910
0
-
-
Sales/maturities of investments
174,836
138,075
0
-
-
Other investing activities
-
-
206
-
-
Net cash used for investing activities
-23,906
-127,004
-931
0
0
Cash flows from financing activities
Debt repayment
-
-
-
0
0
Common stock issued
30,462
20,807
0
0
0
Common stock repurchased
-
-
-
0
0
Other financing activities
-
-
-261
1
6
Net cash used provided by (used for) financing activities
31,610
21,117
457
1,362
9,005
Net change in cash
-141,770
-265,614
-201,438
-9,343
3,700
Cash at beginning of period
259,988
393,644
595,082
16,570
12,870
Cash at end of period
117,902
128,030
393,644
7,227
16,570
Free cash flow
Operating cash flow
-149,790
-160,342
-200,546
-10,630
-5,825
Capital expenditure
-
-169
-1,137
-
-
Free cash flow
-149,871
-160,511
-201,683
-10,630
-5,825